Expecting a growth rate of 40% in FY12: Granules IndiaPublished on Wed, Jan 25, 2012 at 15:34 | Source : CNBC-TV18 Updated at Wed, Jan 25, 2012 at 19:09
C Krishna Prasad, MD, Granules India , spoke to CNBC-TV 18 about the company's performance and what to expect in the days to come. Below is a verbatim transcript. Also watch the accompanying video Q: You have seen about a 45% growth in your net sales and an equivalent smart improvement in your operating profits as well. Is this growth run-rate likely to continue? Q: So what would FY12 and FY13 look like? Q: In terms of key growth drivers, geographically and segment wise, where is this majority growth coming for you? Q: What about the Indian markets? Do you operate in the Indian markets at all and what would be your trajectory there? A: We do operate in Indian market. It's very low volume. We sell only APIs. PFIs and FDs are only for the export markets. Sales in the domestic markets are falling. This year they will be 9%. We are short of capacity today but as we increase capacities, we will be concentrating on the domestic market too. Q: This JV that you have signed with Ajinomoto OmniChem, is it quite significant and will it contribute to your revenues in FY13 or will it come in later?
PREVIOUS STORY Trending NewsBusiness NewsTags: C Krishna Prasad, Granules India |
NewsVideos
Interviews
May 27 2012, 11:52 | Source: CNBC-TV18 ![]() May 27 2012, 11:00 | Source: CNBC-TV18 ![]() Subscribe to Moneycontrol Newsletters |
|||||||